Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Clinical trial NCT07689175 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07689175
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-31
- Primary completion
- 2031-10-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.